Vertex Pharmaceuticals Common stock, number of votes per share remained flat by 0.0% to $0.25 in Q4 2025 compared to the prior quarter.
Changes in voting rights can signal shifts in corporate control or the implementation of dual-class share structures.
This defines the voting rights associated with each share of common stock. It is a key indicator of corporate governance...
Standard governance disclosure for all publicly traded companies.
other_common_stock_votes_per_each_share| FY'25 | |
|---|---|
| Value | $1.00 |